The Childhood Cancer Blog
The Childhood Cancer Blog
Several weeks ago, Alex’s Lemonade Stand Foundation (ALSF) made the decision to close the Foundation’s brick and mortar office and move Team Alex to their home offices. This pivot has made our team stronger than ever — and made all of us growing experts at remote work.
Team Alex has always been comprised of amazing individuals who excel at making lemonade when handed lemons. We are finding new ways to fight childhood cancer and to spread the optimistic, hopeful outlook that has guided ALSF from the beginning.
Here are three feel-good stories from the Foundation:
1... Read More
The impact of the COVID-19 pandemic has extended farther than many of us could have imagined. In this chaotic period, we feel an extra dose of gratitude for the supporters who have helped Alex’s Lemonade Stand Foundation (ALSF) and the fight for cures for childhood cancer. Our culinary community has remained a dedicated ally.
Incredible chefs have cooked, shared recipes, hosted lemonade stands, organized events and lent their world-class talents to support our mission. In 2019 alone, over 100 chefs around the country... Read More
![University of Colorado Denver investigator and ALSF Young Investigator grantee Dr. Jean Mulcahy-Levy has been studying chloroquine and hydroxychloroquine for nearly 11 years as a potential therapy for children with brain tumors with the BRAF mutation. University of Colorado Denver investigator and ALSF Young Investigator grantee Dr. Jean Mulcahy-Levy has been studying chloroquine and hydroxychloroquine for nearly 11 years as a potential therapy for children with brain tumors with the BRAF mutation.](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/jean_levy.jpg?itok=0C6mD8Ky)
University of Colorado Denver investigator and ALSF Young Investigator grantee Dr. Jean Mulcahy-Levy has been studying chloroquine and hydroxychloroquine for nearly 11 years as a potential therapy for children with brain tumors with the BRAF mutation.
![Dr. Stephanie Hicks, from the Johns Hopkins Bloomberg School of Public Health and ALSF Crazy 8 Initiative grantee, is working to create the tools required to analyze childhood cancer data at the single-cell level. Dr. Stephanie Hicks, from the Johns Hopkins Bloomberg School of Public Health and ALSF Crazy 8 Initiative grantee, is working to create the tools required to analyze childhood cancer data at the single-cell level.](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/hicks_small.jpg?itok=8pTXJc7S)
Dr. Stephanie Hicks, from the Johns Hopkins Bloomberg School of Public Health and ALSF Crazy 8 Initiative grantee, is working to create the tools required to analyze childhood cancer data at the single-cell level.
![Dr. Michelle Monje has been funded by ALSF through several grant programs to study DIPG and is currently co-leading the Crazy 8 Initiative’s High-Grade Glioma working group.](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/michelle_monje_0.jpg?itok=w4t1kgwd)
Dr. Michelle Monje has been funded by ALSF through several grant programs to study DIPG and is currently co-leading the Crazy 8 Initiative’s High-Grade Glioma working group.
![Above, Dr. Yael Mosse, MD from the Children’s Hospital of Philadelphia, together with two of patients Edie and Emily Gilger, shares the remarkable story of a research breakthrough with guests at the 2019 Lemon Ball.](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/mosse.jpg?itok=3E6D1TrR)
Above, Dr. Yael Mosse, MD from the Children’s Hospital of Philadelphia, together with two of patients Edie and Emily Gilger, shares the remarkable story of a research breakthrough with guests at the 2019 Lemon Ball.
![Above, Dr. Jennifer Foster with her patient Eden Green. Dr. Foster led a clinical trial for children with relapsed solid tumors.](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/foster.jpg?itok=0TLNRDcX)
Above, Dr. Jennifer Foster with her patient Eden Green. Dr. Foster led a clinical trial for children with relapsed solid tumors.
Every day, 43 children are diagnosed with childhood cancer in the United States. Globally, cancer stole 11.5 million years of healthy life away from children in 2017. Childhood cancer diagnoses don’t stop and neither do the dedicated researchers working to make childhood cancer history.
Alex’s Lemonade Stand Foundation (ALSF) works to fund researchers at all points in their career — from the Pediatric Oncology Student Training (POST)... Read More
Pages